BioLife Solutions, Inc. (BLFS): Price and Financial Metrics


BioLife Solutions, Inc. (BLFS): $14.64

0.83 (+6.01%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BLFS POWR Grades


  • Value is the dimension where BLFS ranks best; there it ranks ahead of 55.2% of US stocks.
  • BLFS's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • BLFS's current lowest rank is in the Growth metric (where it is better than 2.1% of US stocks).

BLFS Stock Summary

  • BLFS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 896.84 -- higher than 96.35% of US-listed equities with positive expected earnings growth.
  • BLFS's current price/earnings ratio is 198.67, which is higher than 96.88% of US stocks with positive earnings.
  • With a year-over-year growth in debt of 3,638.28%, Biolife Solutions Inc's debt growth rate surpasses 99.43% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Biolife Solutions Inc are YEXT, RMO, FUBO, MARK, and TDOC.
  • Visit BLFS's SEC page to see the company's official filings. To visit the company's web site, go to www.biolifesolutions.com.

BLFS Valuation Summary

  • In comparison to the median Healthcare stock, BLFS's price/sales ratio is 182.82% higher, now standing at 32.1.
  • Over the past 243 months, BLFS's EV/EBIT ratio has gone down 190.6.
  • BLFS's price/sales ratio has moved up 31.2 over the prior 243 months.

Below are key valuation metrics over time for BLFS.

Stock Date P/S P/B P/E EV/EBIT
BLFS 2021-08-31 32.1 5.3 671.3 -190.9
BLFS 2021-08-30 32.1 5.2 670.9 -190.7
BLFS 2021-08-27 30.6 5.0 639.5 -181.6
BLFS 2021-08-26 31.1 5.1 650.8 -184.9
BLFS 2021-08-25 30.6 5.0 639.7 -181.7
BLFS 2021-08-24 25.5 4.2 534.8 -151.3

BLFS Growth Metrics

    The year over year revenue growth rate now stands at 56.3%.
  • Its 2 year price growth rate is now at 106.66%.
  • The 5 year net income to common stockholders growth rate now stands at 469.22%.
BLFS's revenue has moved up $89,776,795 over the prior 67 months.

The table below shows BLFS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 96.577 -1.562 4.748
2021-06-30 74.056 -4.147 3.538
2021-03-31 52.772 7.778 -20.503
2020-12-31 48.087 6.645 2.45
2020-09-30 41.657 3.385 -11.387
2020-06-30 36.982 5.024 -0.938

BLFS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BLFS has a Quality Grade of D, ranking ahead of 17.91% of graded US stocks.
  • BLFS's asset turnover comes in at 0.249 -- ranking 137th of 186 Medical Equipment stocks.
  • MASI, NVNO, and ZYXI are the stocks whose asset turnover ratios are most correlated with BLFS.

The table below shows BLFS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.249 0.491 -0.211
2021-03-31 0.269 0.552 -0.611
2020-12-31 0.301 0.571 -0.032
2020-09-30 0.335 0.593 -0.621
2020-06-30 0.383 0.615 -0.137
2020-03-31 0.417 0.654 0.904

BLFS Price Target

For more insight on analysts targets of BLFS, see our BLFS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $62.14 Average Broker Recommendation 1.56 (Moderate Buy)

BLFS Stock Price Chart Interactive Chart >

Price chart for BLFS

BLFS Price/Volume Stats

Current price $14.64 52-week high $60.67
Prev. close $13.81 52-week low $10.40
Day low $13.67 Volume 355,400
Day high $14.76 Avg. volume 433,817
50-day MA $13.34 Dividend yield N/A
200-day MA $29.02 Market Cap 620.88M

BioLife Solutions, Inc. (BLFS) Company Bio


BioLife Solutions, Inc. develops, manufactures, and markets patented tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, and delayed-onset cell damage and death. The company was founded in 1987 and is based in Bothell, Washington.


BLFS Latest News Stream


Event/Time News Detail
Loading, please wait...

BLFS Latest Social Stream


Loading social stream, please wait...

View Full BLFS Social Stream

Latest BLFS News From Around the Web

Below are the latest news stories about Biolife Solutions Inc that investors may wish to consider to help them evaluate BLFS as an investment opportunity.

BioLife Solutions to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on February 28, 2022

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's fourth quarter and full year 2021 financial results will be released after market close on Monday, February 28th. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and a genera

Yahoo | February 21, 2022

PETQ or BLFS: Which Is the Better Value Stock Right Now?

PETQ vs. BLFS: Which Stock Is the Better Value Option?

Yahoo | February 11, 2022

Is BioLife Solutions (NASDAQ:BLFS) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Yahoo | February 2, 2022

Horan Capital Advisors, LLC. Buys BorgWarner Inc, Cincinnati Bancorp Inc, Schwab Emerging ...

Cincinnati, OH, based Investment company Horan Capital Advisors, LLC. (Current Portfolio) buys BorgWarner Inc, Cincinnati Bancorp Inc, Schwab Emerging Markets Equity ETF, Intercontinental Exchange Inc, Coca-Cola Co, sells AT&T Inc, iShares Core MSCI Emerging Markets ETF, Eaton Corp PLC, BioLife Solutions Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Horan Capital Advisors, LLC..

Yahoo | February 1, 2022

Peoples Bank Buys BioLife Solutions Inc, iShares 0-5 Year TIPS Bond ETF, SPDR Portfolio Short ...

Investment company Peoples Bank (Current Portfolio) buys BioLife Solutions Inc, iShares 0-5 Year TIPS Bond ETF, SPDR Portfolio Short Term Corporate Bond ETF, General Motors Co, Air Transport Services Group Inc, sells Cummins Inc, Rio Tinto PLC, Citigroup Inc, Pioneer Natural Resources Co, Dow Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Peoples Bank .

Yahoo | January 27, 2022

Read More 'BLFS' Stories Here

BLFS Price Returns

1-mo 3.39%
3-mo -38.02%
6-mo -60.74%
1-year -67.62%
3-year -6.75%
5-year 458.78%
YTD -60.72%
2021 -6.57%
2020 146.54%
2019 34.50%
2018 100.50%
2017 272.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5209 seconds.